Life Sciences (ATAI) announced the commencement of a proposed registered underwritten offering of $55M of its common shares. All common ...
Keefe Bruyette analyst Ryan Krueger lowered the firm’s price target on Aflac (AFL) to $104 from $107 and keeps a Market Perform rating on the ...